A randomized open label efficacy clinical trial of oral guava leaf decoction in patients with acute infectious diarrhoea

BACKGROUND: Diarrhoea is amongst the first ten causes of death and its treatment faces an increased threat of drug resistance. Previous studies on the guava leaf decoction (GLD) revealed its suitability for use in infectious diarrhoea of unknown etiology. OBJECTIVE: The objective of this trial was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Birdi, Tannaz, Krishnan, G.Geetha, Kataria, Sushila, Gholkar, Manasi, Daswani, Poonam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research Article- Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329711/
https://www.ncbi.nlm.nih.gov/pubmed/32507357
http://dx.doi.org/10.1016/j.jaim.2020.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329711/
https://www.ncbi.nlm.nih.gov/pubmed/32507357
http://dx.doi.org/10.1016/j.jaim.2020.04.001

Ejemplares similares